The life sciences industry is influencing how insurers assess, price, and deliver coverage. Advances in technology, research, and data collection are prompting changes that could reshape the future of risk management.
Dan Pardo, associate casualty broker at Bridge Specialty, has been closely following the ways in which the life sciences sector is reshaping insurance. He said the rapid pace of scientific advancement is creating both new opportunities and new challenges for insurers.
“New breakthroughs in biotechnology, personalized medicine and diagnostics are enabling earlier detection and more effective treatment of diseases,” he said. “For insurers, this means a shift in how risks are assessed, premiums are calculated, and policies are structured.”
Pardo explained that one of the most significant developments is the expansion of personalized medicine. He noted that these tailored treatments are changing how insurers think about underwriting and coverage.
“Treatments are tailored to an individual’s genetic makeup,” he said. “This level of precision allows for better disease prevention and management but also challenges insurers to update underwriting models and coverage plans. In the future, policies may become more customized, reflecting an individual’s unique health profile and risk factors.”
He also discussed the impact of wearable devices and real-time health monitoring. These technologies, often driven by life sciences research, are giving insurers more accurate data for risk assessment.
“These tools are providing insurers with more accurate, up-to-date data,” Pardo said. “This helps improve risk prediction and may lead to discounts or incentives for healthy behaviors, much like usage-based car insurance.”
While innovation is opening new possibilities, Pardo pointed out that it also raises important issues. He said questions around data privacy, genetic testing, and equitable access to care need to be addressed in step with technological progress.
“The rapid pace of change raises ethical and regulatory questions, particularly around data privacy, genetic testing and access to care,” he said. “Insurers, regulators and life sciences companies must work together to ensure that innovations benefit consumers without creating discrimination or inequity.”
Pardo noted the size and momentum of the industry as a factor influencing insurance trends. He highlighted the biotechnology sector, in particular, as a key driver of growth.
“As of 2023, it was valued at $412.74 billion, encompassing major sectors like biotechnology, pharmaceuticals and healthcare services,” he said. “Among these, the biotechnology sector is seeing especially rapid growth. The biotech market alone is projected to soar to $727.1 billion in 2025.”
He identified Boston, San Francisco, and San Diego as established US life science clusters, with Pittsburgh and Houston emerging as new hubs. In these locations, companies face risks that require specialized insurance solutions.
“Life science businesses in these major markets – from early-stage start-ups to multinational corporations – face unique and complex risks that require tailored insurance solutions,” he said. “These risks span across research, manufacturing, clinical trials and global distribution.”
When looking ahead, Pardo believes the insurance industry is moving toward prevention rather than solely responding to losses. He said this will require a deeper integration of health data, analytics, and collaboration with healthcare providers.
“Historically, insurance has been a reactive force – stepping in to cover losses after illness, injury, or error,” he said. “But looking ahead, we can expect a fundamental shift: insurers and healthcare partners becoming more proactive, focusing not just on covering illness, but helping to prevent it.”
This shift, he added, is being fueled by innovations in analytics and data integration. Partnerships with healthcare and life sciences organizations are creating opportunities to embed preventive measures into patient care.
“Partnerships with life sciences and healthcare innovators are allowing insurers to integrate prevention directly into patient journeys,” Pardo said.
He also noted that this evolving approach is generating demand for different types of insurance products. These include coverage structures designed for both domestic and global operations.
“As a result, there are multiple types of insurance solutions, such as business owner’s policies, commercial package policies and global insurance programs with local admitted policies as needed,” he said.
From his position as a wholesale broker, Pardo sees Bridge Specialty Group as well-positioned to address these needs.
“Bridge Specialty Group is informed and equipped to place these types of coverage. We have both the markets and relationships established to do so effectively and competitively,” he said.
What are your thoughts on this story? Please feel free to share your comments below.
